Showing results (511-520 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|April 1, 2021
Association of Albumin-Bilirubin Grade and Sequential Treatment with Standard Systemic Therapies for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study Using a Japanese Administrative DatabaseAtsushi Hiraoka, Yoshinori Tanizawa, Yu-Jing Huang, et al.
Drugs - Real World Outcomes|May 13, 2023
Strategies to Address Current Challenges in Real-World Evidence Generation in JapanThomas Laurent, Dimitra Lambrelli, Ryozo Wakabayashi, et al.
Drugs - Real World Outcomes|May 17, 2023
Identifying Measures of Suboptimal Healthcare Interaction (SOHI) to Develop a Claims-Based Model for Predicting Patients with Inflammatory Bowel Disease at Risk for SOHIStephanie Korrer, April N Naegeli, Lida Etemad, et al.
Drugs - Real World Outcomes|August 16, 2025
Real-World Ibrexafungerp Use Patterns Among Patients with Commercial Health Insurance, United States, 2021-2023Kaitlin Benedict, Dallas J Smith, Jeremy A W Gold
Drugs - Real World Outcomes|August 5, 2025
Effectiveness and Safety of Long-Term Venous Thromboembolism Prophylaxis After Colorectal Cancer Surgery: A Retrospective StudyYing Zhang, Xiaozhu Zhou, Yi Wu, et al.
Drugs - Real World Outcomes|October 28, 2025
Sodium Zirconium Cyclosilicate Duration and Hyperkalemia-Related Healthcare Encounters in Patients with Heart Failure and Cardio/Renal Dysfunction: The GALVANIZE Outcome StudyAbiy Agiro, Fan Mu, Erin E Cook, et al.
Drugs - Real World Outcomes|July 15, 2025
Treatment Patterns and Characteristics of Patients with Hereditary Angioedema Treated with Lanadelumab: A US Retrospective Chart ReviewMaureen Watt, Rose Chang, Louise Huafeng Yu, et al.
Drugs - Real World Outcomes|July 10, 2025
Effectiveness of Glipizide and Glipizide Plus Metformin Formulation among Asian Indians with Type 2 Diabetes: a Real-World, Retrospective Electronic Medical Record AnalysisThyparambil Aravindakshan PramodKumar, Rajendra Pradeepa, Saravanan Jebarani, et al.
Drugs - Real World Outcomes|June 16, 2025
Estimating Risks of Central Nervous System Disturbance Associated with Medications for Herpes Zoster: Findings from a Regional Population-Based Cohort Study Using the Shizuoka Kokuho DatabaseRyoya Hagiwara, Eiji Nakatani, Hideaki Kaneda, et al.
Drugs - Real World Outcomes|June 19, 2025
Assessment of Burden of Partial Response to Standard Doses of Proton Pump Inhibitors in Patients with Clinically Diagnosed Gastroesophageal Reflux Disease: A Real-World Evidence Study in IndiaYogesh Garje, Rajiv Saikia, Sunil Gupta, et al.
Pageof 55